Literature DB >> 21098682

Defining a relationship between dietary fatty acids and the cytochrome P450 system in a mouse model of fatty liver disease.

Monika Gonzalez1, Whitney Sealls, Elliot D Jesch, M Julia Brosnan, Istvan Ladunga, Xinxin Ding, Paul N Black, Concetta C DiRusso.   

Abstract

Liver-specific ablation of cytochrome P450 reductase in mice (LCN) results in hepatic steatosis that can progress to steatohepatitis characterized by inflammation and fibrosis. The specific cause of the fatty liver phenotype is poorly understood but is hypothesized to result from elevated expression of genes encoding fatty acid synthetic genes. Since expression of these genes is known to be suppressed by polyunsaturated fatty acids, we performed physiological and genomics studies to evaluate the effects of dietary linoleic and linolenic fatty acids (PUFA) or arachidonic and decosahexaenoic acids (HUFA) on the hepatic phenotypes of control and LCN mice by comparison with a diet enriched in saturated fatty acids. The dietary interventions with HUFA reduced the fatty liver phenotype in livers of LCN mice and altered the gene expression patterns in these livers to more closely resemble those of control mice. Importantly, the expression of genes encoding lipid pathway enzymes were not different between controls and LCN livers, indicating a strong influence of diet over POR genotype. These analyses highlighted the impact of POR ablation on expression of genes encoding P450 enzymes and proteins involved in stress and inflammation. We also found that livers from animals of both genotypes fed diets enriched in PUFA had gene expression patterns more closely resembling those fed diets enriched in saturated fatty acids. These results strongly suggest only HUFA supplied from an exogenous source can suppress hepatic lipogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098682      PMCID: PMC3055711          DOI: 10.1152/physiolgenomics.00209.2010

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  50 in total

1.  The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.

Authors:  Yin Liang; Pengxiang She; Xiwei Wang; Keith Demarest
Journal:  Metabolism       Date:  2006-10       Impact factor: 8.694

2.  Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.

Authors:  Yan Weng; Concetta C DiRusso; Andrew A Reilly; Paul N Black; Xinxin Ding
Journal:  J Biol Chem       Date:  2005-07-08       Impact factor: 5.157

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 4.  Docosahexaenoic acid (DHA) and hepatic gene transcription.

Authors:  Donald B Jump; Daniela Botolin; Yun Wang; Jinghua Xu; Olivier Demeure; Barbara Christian
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

5.  Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.

Authors:  Stella Koutros; Sonja I Berndt; Rashmi Sinha; Xiaomei Ma; Nilanjan Chatterjee; Michael C R Alavanja; Tongzhang Zheng; Wen-Yi Huang; Richard B Hayes; Amanda J Cross
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

6.  Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1.

Authors:  Ke-Da Yu; Lei Fan; Gen-Hong Di; Wen-Tao Yuan; Ying Zheng; Wei Huang; Ao-Xiang Chen; Chen Yang; Jiong Wu; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-10-24       Impact factor: 4.872

Review 7.  NGAL: a biomarker of acute kidney injury and other systemic conditions.

Authors:  Sachin S Soni; Dinna Cruz; Ilona Bobek; Chang Yin Chionh; Federico Nalesso; Paolo Lentini; Massimo de Cal; Valentina Corradi; Grazia Virzi; Claudio Ronco
Journal:  Int Urol Nephrol       Date:  2009-07-07       Impact factor: 2.370

8.  KEGG Atlas mapping for global analysis of metabolic pathways.

Authors:  Shujiro Okuda; Takuji Yamada; Masami Hamajima; Masumi Itoh; Toshiaki Katayama; Peer Bork; Susumu Goto; Minoru Kanehisa
Journal:  Nucleic Acids Res       Date:  2008-05-13       Impact factor: 16.971

9.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

Review 10.  The UPS in diabetes and obesity.

Authors:  Simon S Wing
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

View more
  7 in total

1.  Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology.

Authors:  Saraswoti Khadge; John Graham Sharp; Geoffrey M Thiele; Timothy R McGuire; Lynell W Klassen; Michael J Duryee; Holly C Britton; Alicia J Dafferner; Jordan Beck; Paul N Black; Concetta C DiRusso; James Talmadge
Journal:  J Nutr Biochem       Date:  2017-10-04       Impact factor: 6.048

2.  Adaptive hepatic and intestinal alterations in mice after deletion of NADPH-cytochrome P450 Oxidoreductase (Cpr) in hepatocytes.

Authors:  Xingguo Cheng; Jun Gu; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2014-08-21       Impact factor: 3.922

3.  Long-Chain Omega-3 Polyunsaturated Fatty Acids Modulate Mammary Gland Composition and Inflammation.

Authors:  Saraswoti Khadge; Geoffrey M Thiele; John Graham Sharp; Timothy R McGuire; Lynell W Klassen; Paul N Black; Concetta C DiRusso; James E Talmadge
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-25       Impact factor: 2.673

4.  The role of cytochrome P450-dependent metabolism in the regulation of mouse hepatic growth hormone signaling components and target genes by 3-methylcholanthrene.

Authors:  Chunja Lee; Xinxin Ding; David S Riddick
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

5.  A neurotoxic alcohol exposure paradigm does not induce hepatic encephalopathy.

Authors:  Joel G Hashimoto; Kristine M Wiren; Clare J Wilhelm
Journal:  Neurotoxicol Teratol       Date:  2016-06-04       Impact factor: 3.763

6.  NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.

Authors:  David S Riddick; Xinxin Ding; C Roland Wolf; Todd D Porter; Amit V Pandey; Qing-Yu Zhang; Jun Gu; Robert D Finn; Sebastien Ronseaux; Lesley A McLaughlin; Colin J Henderson; Ling Zou; Christa E Flück
Journal:  Drug Metab Dispos       Date:  2012-10-19       Impact factor: 3.922

7.  Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.

Authors:  Yanuo Li; Yan Shi; Yan Sun; Luying Liu; Xianyong Bai; Dong Wang; Hongxing Li
Journal:  Mol Med Rep       Date:  2016-11-24       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.